Clinical trial

Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients…

NCT00270881 · Keio University, Other · Completed

Key facts

NCT number NCT00270881
Title Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies
Official title Phase 1/2 Study of Cord Blood Transplantation From Unrelated Donor for Adult Patients With Hematologic Malignancies Using Myeloablative Conditioning Regimen
Lead sponsor Keio University, Other
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome
Intervention type Drug, Procedure, Radiation
Interventions Cord blood transplantation, TBI, cyclophosphamide, cytarabine
Enrollment 33
Start date Jan 1, 2006
Primary completion Jan 1, 2009
Completion Jan 1, 2011
First posted Dec 29, 2005
Last update posted Apr 6, 2012
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies